نتائج البحث

Infliximab: Pharmacology, Uses and Limitations

• Authors : Medrano Acevedo, Antonio D.; Fajardo Gaitan, Montserrat

Subjects: Infliximab; Infliximab--Therapeutic use; Anti-inflammatory agentsMEDICAL / Immunology

تفاصيل العنوان

Comparative study of a point-of-care test and an enzyme-linked immunosorbent assay (ELISA) for infliximab levels

• Authors : Thunberg, J; Granno, O; Bergemalm, D

Subjects: Medicin och hälsovetenskap

• Source: Scandinavian journal of gastroenterology. 59(2):150-155

تفاصيل العنوان

Does the introduction of an infliximab biosimilar always result in savings for hospitals? A descriptive study using real-world data.

• Authors : Krstic, Marko (AUTHOR); Devaud, Jean-Christophe (AUTHOR); Sadeghipour, Farshid (AUTHOR)

Subjects: LENGTH of stay in hospitals; HOSPITAL costs; TERMINATION of treatmentSWITZERLAND

• Source: Health Economics Review. 4/29/2024, Vol. 14 Issue 1, p1-11. 11p.

تفاصيل العنوان

Effectiveness of switching to subcutaneous infliximab in inflammatory bowel disease patients with inadequate biochemical response during intravenous administration.

• Authors : Lee B; Department of Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea.; Kim M

Subjects: Infliximab*/Infliximab*/Infliximab*/administration & dosage ; Infliximab*/Infliximab*/Infliximab*/therapeutic use ; Infliximab*/Infliximab*/Infliximab*/pharmacokinetics

• Source: Scientific reports [Sci Rep] 2024 Oct 17; Vol. 14 (1), pp. 24347. Date of Electronic Publication: 2024 Oct 17.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Gut microbiota diversity repeatedly diminishes over time following maintenance infliximab infusions in paediatric IBD patients.

• Authors : Carlsen K; Department of Paediatrics and Adolescence, Copenhagen University Hospital-Amager Hvidovre Hospital, Hvidovre, Denmark.; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescent and Adults, Copenhagen University Hospital, Amager and Hvidovre, Hvidovre, Denmark.

Subjects: Infliximab*/Infliximab*/Infliximab*/therapeutic use ; Infliximab*/Infliximab*/Infliximab*/administration & dosage ; Gastrointestinal Microbiome*/Gastrointestinal Microbiome*/Gastrointestinal Microbiome*/drug effects

• Source: PloS one [PLoS One] 2024 Dec 12; Vol. 19 (12), pp. e0311604. Date of Electronic Publication: 2024 Dec 12 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

Budget impact analysis of subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in Saudi Arabia: Analysis from payer perspective.

• Authors : Alkhatib NS; Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan.; Path Economics, LLC, Amman, Jordan.

Subjects: Infliximab*/Infliximab*/Infliximab*/therapeutic use ; Infliximab*/Infliximab*/Infliximab*/economics ; Infliximab*/Infliximab*/Infliximab*/administration & dosage

• Source: PloS one [PLoS One] 2024 Nov 12; Vol. 19 (11), pp. e0312603. Date of Electronic Publication: 2024 Nov 12 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

The efficacy of CT-P13, a biosimilar of infliximab, in inflammatory bowel diseases: a systematic review and meta-analysis.

• Authors : Hu X; Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.; Tang X

Subjects: Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/therapeutic use ; Infliximab*/Infliximab*/Infliximab*/therapeutic use ; Remission Induction*

• Source: BMC gastroenterology [BMC Gastroenterol] 2024 Nov 12; Vol. 24 (1), pp. 406. Date of Electronic Publication: 2024 Nov 12.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

تفاصيل العنوان

Adherence to infliximab treatment in patients with immune-mediated inflammatory diseases from a referral center in Brazil: a cohort study.

• Authors : Lauton PM; Faculdade de Farmácia, Universidade Federal da Bahia, Salvador, Brasil.; Programa de Pós-Graduação em Assistência Farmacêutica em Rede e Associação de Instituições de Ensino Superior, Faculdade de Farmácia, Universidade Federal da Bahia, Salvador, Brasil.

Subjects: Infliximab*/Infliximab*/Infliximab*/therapeutic use ; Medication Adherence*/Medication Adherence*/Medication Adherence*/statistics & numerical data ; Gastrointestinal Agents*/Gastrointestinal Agents*/Gastrointestinal Agents*/therapeutic use

• Source: BMC gastroenterology [BMC Gastroenterol] 2024 Oct 29; Vol. 24 (1), pp. 384. Date of Electronic Publication: 2024 Oct 29.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

تفاصيل العنوان

Pharmacokinetic comparison of subcutaneously administered CT-P13 (biosimilar of infliximab) via autoinjector and pre-filled syringe in healthy participants.

• Authors : Park YC; Clinical Trials Center, Chungnam National University Hospital, Daejeon, Korea.; Department of Medical Science, Chungnam National University College of Medicine, Daejeon, Korea.

Subjects: Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/pharmacokinetics ; Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/administration & dosage ; Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/blood

• Source: Clinical and translational science [Clin Transl Sci] 2024 Oct; Vol. 17 (10), pp. e70037.Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure.

• Authors : June Hwa Bae¹; Jung-Bin Park¹; Ji Eun Baek¹

• Source: Gut & Liver. Jul2024, Vol. 18 Issue 4, p667-676. 10p.

تفاصيل العنوان